Physician profile
Casey R Boyce
NPI 1093847253
$1,948.24
in general payments reported to CMS, 2019-2025
26 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $28.84 · 2021: $381 · 2022: $379 · 2023: $621 · 2024: $223 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $991.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $291.71 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coopersurgical, INC. | $267.41 | 2019-2024 | Paragard T 380a, Paragard T 380a, Endosee |
| Abbvie INC. | $159.21 | 2020-2023 | Lo Loestrin Fe, Liletta |
| Hologic Sales and Service, LLC | $132.84 | 2019-2023 | Novasure, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $128.12 | 2020-2025 | Veozah |
| Aspira Women'S Health INC | $101.90 | 2023 | Ova1 |
| Exeltis, USA INC. | $98.60 | 2021-2024 | Slynd |
| Merck Sharp & Dohme LLC | $96.07 | 2019-2023 | Gardasil 9 |
| Novo Nordisk INC | $92.04 | 2021-2025 | Wegovy |
| Pfizer INC. | $81.12 | 2021-2023 | |
| Therapeuticsmd, INC. | $69.47 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $59.37 | 2023-2025 | Myfembree |
| Exact Sciences Corporation | $46.46 | 2023 | Cologuard Collection Kit |
| Organon LLC | $44.40 | 2021-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $34.51 | 2019-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $33.73 | 2025 | Perclot, Tisseel |
| Sanara Medtech INC. | $30.47 | 2021 | |
| Currax Pharmaceuticals LLC | $28.85 | 2023-2024 | Contrave |
| Agile Therapeutics, INC. | $24.58 | 2022 | |
| Urovant Sciences INC | $23.58 | 2022 | |
| Millicent US INC | $22.35 | 2025 | Femlyv |
| Sage Therapeutics, LLC | $21.33 | 2024 | |
| Ge Healthcare | $20.53 | 2023 | |
| Ethicon US, LLC | $18.82 | 2022 | |
| Amgen INC. | $16.97 | 2019 | |
| Mayne Pharma Commercial LLC | $3.80 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Boyce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.